Develops, manufactures and markets hemoglobin-based oxygen therapeutic products which are intravenously administered into the circulatory system to increase oxygen delivery to the body's tissues. (Nasdaq: BPUR).
Develops systems designed to improve safety of blood transfusions by inactivating infectious pathogens in blood components, platelets, fresh frozen plasma and red blood cells, and to inhibit leukocyte activity. Details of system and company based in Concord, California. (Nasdaq: CERS).
Develops, manufactures, and sells reagents and systems used to detect and identify cell and serum components of human blood prior to blood transfusions. International distriubuter contacts, with headquarters in Norcross, Georgia, USA. (Nasdaq: BLUD).
Develops, safe and effective alternatives to transfer blood for use in the treatment of acute blood loss, including polyheme a solution of chemically modified hemoglobin, which loads and unloads oxygen in the same manner as transfused blood. (Nasdaq: NFLD).
Develops, manufactures and markets innovative medical products such as disposable catheters which utilize pressurized saline jets to remove blood clots, and synthetic grafts which act as substitutes for native blood vessels used in coronary artery bypass surgery.
